Jeffrey Dunn, MD

Publications

• Protective Effect of elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin olidodendrocyte glycoprotein Herges K, DeJong BA, Kolkowitz I, Dunn C, Mandelbaum G, Maini A, Han M, Killestein J, Polman C, Goodyear A, Dunn J, Steinman L, Axtell RC. Multiple Sclerosis. 2012; 18 (4): 398-408
• Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein. Herges K, de Jong BA, Kolkowitz I, Dunn C, Mandelbaum G, Ko RM, Maini A, Han MH, Killestein J, Polman C, Goodyear AL, Dunn J, Steinman L, Axtell RC. Mult Scler. 2012; 18 (4): 398-408
• Dalfampridine: A brief review of its Mechanism of Action and Efficacy as a treatment to improve walking in patients with Multiple Sclerosis Dunn J, Blight A. Current Research Medical Opinion. 2011; 27 (7): 1415-1423
• Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis. Dunn J, Blight A. Curr Med Res Opin. 2011; 27 (7): 1415-23
• Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. Wynn D, Kaufman M, Montalban X, Vollmer T, Simon J, Elkins J, O'Neill G, Neyer L, Sheridan J, Wang C, Fong A, Rose JW. Lancet Neurol. 2010; 9 (4): 381-90
• Impact of mobility impairment on the burden of caregiving in individuals with multiple sclerosis. Dunn J, Expert Rev Pharmacoecon Outcomes Res. 2010; 10 (4): 433-40
• The impact of mobility impairment on the burden of caregiving in individuals with multiple sclerosis Dunn, J., Expert Rev. Pharmacoeconomics Outcomes Res.. 2010; 10 (4): 433-440
• CMV Optic Neuritis with Extensive Tracking along the Visual Pathway Pershing S, Dunn J, Khan A, Liao JY, J Neuro-Ophthalmology. 2009; 29 (3): 223-226
• Cytomegalovirus infection with MRI signal abnormalities affecting the optic nerves, optic chiasm, and optic tracts. Pershing S, Dunn J, Khan A, Liao YJ. J Neuroophthalmol. 2009; 29 (3): 223-6
• Glatiramer Acetate after Induction Therapy with Mitoxantrone in Relapsing Multiple Sclerosis Vollmer T, Panitch H, Bar-Or A, Dunn J, Freedman MS, Gazda SK,Campagnolo D, Deutsch F, Arnold D, Multiple Sclerosis. 2008 Apr 18
• Glatiramer Acetate after Mitoxantrone Induction improves MRI markers of lesion volume and permanent tissue injury in MS Arnold D., Campagnolo D., Panitch H., Bar-Or A., Dunn J, Freedman M., Gazda S.K., Vollmer T., J Neurol. 2008: 255 1473-1478
• Tovaxin for Early Relapsing Multiple Sclerosis Phase 2b Placebo Controlled Trial of Autologous T cell vaccination in patients with CIS or RRMS Fox, EJ, The TERMS Study Investigators. Multiple Sclerosis. 2008: 14 S5-S27
• Daclizumab in Patients with Active Relapsing Multiple Sclerosis on Concurrent Interferon beta Therapy; Week 24 data Phase II Montalban X,Kaufman M, Wynn D et Dunn J with the CHOICE Study Investigators, ECTRIMS. 2007: 10/11/07 S18
• Randomized, Double Blind, Dose Comparison Study of Glatiramer Acetate in Relapsing Remitting MS Cohen JA, Rovaris M, Goodman AD, Ladkani D, Wynn D, Filippi M, 9006 Study Group, Neurology. 2007; 68 (12): 939-944
• Safety and Tolerability of Glatiramer Acetate in Pediatric Patients with Relapsing Remitting Multiple Sclerosis Krupp L, Banwell B, Picone M, Dunn J, Weinstock-Guttman B, Pardo L., ECTRIMS/ACTRIMS. 2005; (September): abstract
• Comprehensive Outpatient Management of Patients with Multiple Sclerosis Odderson I, Dunn J, RIMS MS Symposium. 2001; (May): abstract
• Novantrone in the Treatment of Multiple Sclerosis Dunn Jeffrey, Kita M., Lucas S., Bowen J.,, Alliance News. 2001: 1-3
• Clinical Advisory Committee Statement Bowen J., Dunn Jeffrey E., Kraft G.H., Ratley G., Shilling J., Smith C., Thompson L., Health Care Connection. 1999; I (1): 1-2
• Gingko Biloba in the Treatment of Alzheimer's Disease Dunn Jeffrey E., Maidan R., Pallis J., Alternative Medicine. 1998; 1 (15): 1-2
• Atherosclerotic Aortic Disease as a Source of Embolic Infarct Bursell John P.,Odderson I., Dunn Jeffrey E., Journal of Neurovascular Disease. 1996; 1 (2): 35-38
• Intracerebral Bacillary Angiomatosis in a Patient Infected with HIV Spach, D., Panther L., Thorning D., Dunn Jeffrey E., Plorde J.L., Miller,R.. Annals of Internal Medicine. 1992: 116 740-743
• Intracerebral bacillary angiomatosis in a patient infected with human immunodeficiency virus. Spach DH, Panther LA, Thorning DR, Dunn JE, Plorde JJ, Miller RA. Ann Intern Med. 1992; 116 (9): 740-2